Previous Executive Club Meetings
14th Dinner Meeting
Speaker: Mads Krogsgaard, CSO Novo Nordisk and member of the Life Science Growth Team
Theme: “The Government´s Life Science Growth Team: Recommendations for a Danish Life Science strategy”
13th Brunch Meeting
Speaker: Carsten Borring, Head of Listings & Capital Markets at Nasdaq Copenhagen
Theme: “Nasdaq – boosting the life science ecosystem in the Nordics”
12th Dinner Meeting
Speaker: Peter Høngaard Andersen, Director Danish National Innovation Foundation
Theme: “Drivers and Barriers for innovation in life science and healthcare”
11th Dinner Meeting
Speakers: Pia Kinhult, former First Governor of Skåne, is now Strategic Advisor at the ESS, European Spallation Source, and Martin Vang Hansen CFO and Vice President at The Danish Growth Fund.
Theme: “Growth and Investment in Medicon Valley – with a focus on job creation, start-ups, and risk capital”
10th Dinner Meeting
Speakers: Friis Arne Petersen Ambassador of Denmark to the People’s Republic of China and Mongolia and Ulf Wiinberg, President & CEO at H. Lundbeck. View their bio’s here.
Theme: “Chinese Healthcare reforms offer unique opportunities for Medicon Valley Stakeholders”
9th Dinner Meeting
Speakers: Mike Rulis, Corporate Vice President and Head of Corporate Communications, Novo Nordisk A/S and Colin Carlile, Special advisor to the CEO, Science Village Scandinavia. View their bio’s here.
Theme: “Value-creating communication within life science”
8th Dinner Meeting
Speakers: Martin Bonde, CEO in EpiTherapeutics & Chairman of the board in DANSK BIOTEK, Dr. David Solomon, President & Chief Executive Officer in ZealandPharma and Tomas Leanderson, President & CEO in Active Biotech. View their bio’s here.
Theme: “Growth and development for biotech companies in Medicon Valley”
7th Dinner Meeting
Speaker: Dr. Mary L. Walshok, auther, educator and community leader. View Mary L. Walshok’s bio.
Theme: “The story of San Diego’s innovation economy and its relevance to Medicon Valley”
6th Dinner Meeting
Speakers: Steinar Høeg, External Affairs Director Europe at AstraZeneca and Thomas Lönngren, Strategy Advisor at NDA Group AB former Executive Director of the European Medicines Agency (EMA). View Steinar Høeg’s bioand Thomas Lönngren’s bio.
Theme: “How to address the increasingly importance of health economics?”
5th Dinner Meeting
4th Dinner Meeting
Speaker: Martin Edvards, Senior Advisor at Novo Ventures A/S. View Martin Edvard’s bio.
Theme: “Truth, Lies and Venture Investing”
Speaker: David S. Fushtey, General Counsel at The Governance Counsel in Vancouver, BC, Canada.
Theme: “North America Marktes and Corporate Governance: SOx, Vioxx and OMX”
3th Dinner Meeting
Speakers: David Campbell, Senior Principal in Strategy and Portfolio Analysis and Jesper Elsgaard, Business Unit Lead, Management Consulting, both from IMS Health.
Theme: “More Ways to Win – Quantifying the Future Oppertunities in the Medicines Market. How does the CEO agenda need to evolve through 2020?”
2nd Dinner Meeting
Speakers: Nigel Holden, Professor of Cross-Cultural Management at Lanchashire Business School and Martin Glisby, Director & Co-Founder of Glisby Holden & Associates Ltd. View Nigel Holden and Martin Glisby’s bios.
Theme: “Creating knowledge advantage, the tacit dimensions of international compertition and cooperation”
1st Dinner Meeting
Speaker: Sonja Opper, Gad Rausing Professor of International Economics and Business, Department of Economics,Lund University, Sweden. View Sonja Opper’s CV.
Theme: “China’s new entrepreneurs: A global challenge?”